This inventor holds 1 USPTO granted patent and 1 published patent application and 1 EPO patent. Top assignee: Dongkook Pharmaceutical Co., Ltd.. Active years: 2018.
Company Filing History:
Years Active: 2018
Title: Innovations by Sung Jin Ko in Pharmaceutical Composition
Introduction
Sung Jin Ko is an accomplished inventor based in Gyeonggi-do, South Korea. He has made significant contributions to the field of pharmaceuticals, particularly in the development of innovative drug delivery systems. His work focuses on enhancing the efficacy and convenience of medication administration.
Latest Patents
Sung Jin Ko holds a patent for a pharmaceutical composition for parenteral administration, which contains donepezil as an active ingredient. This invention relates to a composition designed for sustained release, allowing for continuous in vivo release for 2-12 weeks or more. By preparing donepezil as microparticles comprising a biodegradable and biocompatible polymer, the invention reduces the frequency of administration required for patients while maintaining effective blood concentration levels.
Career Highlights
Sung Jin Ko is associated with Dongkook Pharmaceutical Co., Ltd., where he continues to innovate in the pharmaceutical sector. His work has the potential to significantly improve patient compliance and treatment outcomes through advanced drug delivery methods.
Collaborations
Some of his notable coworkers include Deok Keun Lee and Shin Eom, who contribute to the collaborative efforts in research and development within the company.
Conclusion
Sung Jin Ko's innovative approach to pharmaceutical compositions exemplifies the advancements being made in drug delivery systems. His contributions are paving the way for more effective and patient-friendly medication administration methods.